Asupardo, Ricthel .

HRN: 23-60-06  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/31/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/31/2024
02/07/2024
IV
500mg
Q6hr
Sepsis
Waiting Final Action 

Indication:  Empirical Escalation    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: